Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.

Kohler I, Jacob D, Budzies J, Lehmann A, Weichert W, Schulz S, Neuhaus P, Röcken C.

Am J Clin Pathol. 2011 Feb;135(2):202-11. doi: 10.1309/AJCPCTCUQSYI89YT.

PMID:
21228360
2.

Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.

Kwon MJ, Kim JW, Jung JP, Cho JW, Nam ES, Cho SJ, Kim JS, Park HR, Min SK, Seo J, Min KW, Kim DH, Jeon JY.

Hum Pathol. 2016 Apr;50:90-100. doi: 10.1016/j.humpath.2015.11.009. Epub 2015 Nov 30.

PMID:
26997442
3.

Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.

Perysinakis I, Minaidou E, Leontara V, Mantas D, Sotiropoulos GC, Tsipras H, Zografos GN, Margaris I, Kouraklis G.

Int J Surg Pathol. 2017 Feb;25(1):31-40. doi: 10.1177/1066896916664987. Epub 2016 Aug 20.

PMID:
27543509
4.

Survival in ampullary cancer: potential role of different KRAS mutations.

Valsangkar NP, Ingkakul T, Correa-Gallego C, Mino-Kenudson M, Masia R, Lillemoe KD, Fernández-del Castillo C, Warshaw AL, Liss AS, Thayer SP.

Surgery. 2015 Feb;157(2):260-8. doi: 10.1016/j.surg.2014.08.092.

5.

Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.

Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AV.

J Clin Oncol. 2005 Mar 20;23(9):1811-8.

PMID:
15774774
6.

Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.

Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J, Kloeppel G, Sessa F, Edmonston TB, Schneider-Stock R, Klinkhammer-Schalke M, Pauer A, Schick S, Hofstaedter F, Baumhoer D, Hartmann A.

Am J Surg Pathol. 2009 May;33(5):691-704. doi: 10.1097/PAS.0b013e3181983ef7.

PMID:
19252434
7.

Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.

Perysinakis I, Minaidou E, Mantas D, Sotiropoulos GC, Leontara V, Tsipras H, Zografos GN, Margaris I, Kouraklis G.

Pathol Res Pract. 2016 Nov;212(11):1039-1047. doi: 10.1016/j.prp.2016.09.004. Epub 2016 Sep 22.

PMID:
27688085
8.

Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.

Kumari N, Prabha K, Singh RK, Baitha DK, Krishnani N.

Hum Pathol. 2013 Oct;44(10):2213-9. doi: 10.1016/j.humpath.2013.05.003. Epub 2013 Jul 5.

PMID:
23834763
9.
10.

Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.

Chang DK, Jamieson NB, Johns AL, Scarlett CJ, Pajic M, Chou A, Pinese M, Humphris JL, Jones MD, Toon C, Nagrial AM, Chantrill LA, Chin VT, Pinho AV, Rooman I, Cowley MJ, Wu J, Mead RS, Colvin EK, Samra JS, Corbo V, Bassi C, Falconi M, Lawlor RT, Crippa S, Sperandio N, Bersani S, Dickson EJ, Mohamed MA, Oien KA, Foulis AK, Musgrove EA, Sutherland RL, Kench JG, Carter CR, Gill AJ, Scarpa A, McKay CJ, Biankin AV.

J Clin Oncol. 2013 Apr 1;31(10):1348-56. doi: 10.1200/JCO.2012.46.8868. Epub 2013 Feb 25.

PMID:
23439753
11.

Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.

Kwon MJ, Kim JW, Jeon JY, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Min KW, Choe JY, Lee HK.

Pathol Res Pract. 2017 Apr;213(4):381-388. doi: 10.1016/j.prp.2017.01.004. Epub 2017 Jan 11.

PMID:
28214200
12.

p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.

Zhao B, Kimura W, Futakawa N, Muto T, Kubota K, Harihara Y, Takayama T, Makuuchi M.

Am J Gastroenterol. 1999 Aug;94(8):2128-34.

PMID:
10445539
13.

Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Schönleben F, Qiu W, Allendorf JD, Chabot JA, Remotti HE, Su GH.

J Gastrointest Surg. 2009 Aug;13(8):1510-6. doi: 10.1007/s11605-009-0917-4. Epub 2009 May 14.

14.

Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?

Amptoulach S, Josefsson A, Kavantzas N, Kalaitzakis E.

Scand J Gastroenterol. 2011 Nov;46(11):1401-3. doi: 10.3109/00365521.2011.610006. Epub 2011 Aug 19. No abstract available.

PMID:
21854095
15.

LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.

Kermanshahi TR, Jayachandran P, Chang DT, Pai R.

Appl Immunohistochem Mol Morphol. 2014 Nov-Dec;22(10):728-34. doi: 10.1097/PAI.0000000000000109.

PMID:
25394300
16.

Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.

Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, Revetta F, Washington MK, Vnencak-Jones C, Shi C.

Mod Pathol. 2014 May;27(5):665-74. doi: 10.1038/modpathol.2013.185. Epub 2013 Nov 1.

17.

Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.

Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, Castri F, Manazza AD, Santini D, Tonini G, Coppola R, Onetti Muda A.

Pancreas. 2013 Jan;42(1):60-6. doi: 10.1097/MPA.0b013e318258fda8.

PMID:
22889982
18.

Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.

Gheza F, Cervi E, Pulcini G, Villanacci V, Giulini SM, Schiavo-Lena M, Ferrari AB, Bassotti G.

Pancreas. 2011 Jul;40(5):791-3. doi: 10.1097/MPA.0b013e318216db94. No abstract available.

PMID:
21673543
19.

Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.

Ohike N, Kim GE, Tajiri T, Krasinskas A, Basturk O, Coban I, Bandyopadhyay S, Morohoshi T, Goodman M, Kooby DA, Sarmiento JM, Adsay NV.

Am J Surg Pathol. 2010 Dec;34(12):1731-48. doi: 10.1097/PAS.0b013e3181f8ff05.

20.

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jun 11;8:170. doi: 10.1186/1471-2407-8-170.

Supplemental Content

Support Center